CHICAGO - A group of international researchers is making the case that genetic tests that look for multiple hereditary genes suspected of being linked to breast cancer should not be offered until they are proven to be valid and useful in clinical practice.
LONDON - Drinking up to five espressos a day, or the equivalent, poses no risk to the general population, according to a European review into the safety of caffeine.
LONDON - Swiss drugmaker Novartis is raising its bet on smart technology by collaborating with U.S. start-up Rani Therapeutics on a “robotic pill” for complex biotech drugs that would normally have to be given by injection.
SAN FRANCISCO - California scientists are testing whether the illegal psychoactive drug commonly known as Ecstasy could help alleviate anxiety for terminally ill patients, the trial's principal funder said on Tuesday.
- GlobeImmune Inc said its experimental hepatitis B drug did not meet the main goal of reducing infection in patients after 24 weeks, in a mid-stage trial.
(Reuters Health) - Cancer patients under age 65 are much more likely than older people to explore alternative and complementary medicine for easing their symptoms and side effects of treatment, a new study suggests.
(Reuters Health) - In younger women with breast cancer, having a family history of the disease may not worsen their survival odds, a new study suggests.
(Reuters Health) - - Racial minorities may be more likely to forego colon cancer screening than whites because their healthcare providers don’t recommend the potentially life-saving tests, a new study in California suggests.
(Reuters Health) - Waiting a few minutes to clamp the umbilical cord after birth is tied to better motor and social skills later in childhood - especially for boys, suggests a new study.
(Reuters Health) - When older men have stressed-out wives, their own blood pressure may go up, a U.S. study suggests.